Dupilumab treatment induces clinical remission in patients with uncontrolled, moderate-to-severe, type 2 inflammatory asthma

被引:0
|
作者
Pavord, I. [1 ]
Pandit-Abid, N. [2 ]
Israel, E. [3 ,4 ]
Szefler, S. [5 ]
Brusselle, G. [6 ]
Rabe, K. [7 ,8 ]
Chen, Z. [9 ]
Altincatal, A. [10 ]
Amin, N. [9 ]
Khan, A. [11 ]
Lederer, D. H. [9 ]
Zhang, Y. [9 ]
Rowe, P. J. [2 ]
Deniz, Y. [9 ]
Amr, R. [9 ]
Jacob-Nara, J. A. [2 ]
Busse, W. W. [12 ]
机构
[1] Univ Oxford, Oxford, England
[2] Sanofi, Bridgewater, MA USA
[3] Harvard Med Sch, Boston, MA USA
[4] Brigham & Womens Hosp, Boston, MA USA
[5] Univ Colorado, Sch Med, Aurora, CO USA
[6] Ghent Univ Hosp, Ghent, Belgium
[7] LungenClin Grosshansdorf, Grosshansdorf, Germany
[8] Univ Kiel, Kiel, Germany
[9] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[10] Sanofi, Cambridge, MA USA
[11] Sanofi, Chilly Mazarin, France
[12] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
000327
引用
收藏
页码:206 / 207
页数:2
相关论文
共 50 条
  • [21] The assessment of dupilumab in children with moderate-to-severe asthma and comorbid type 2 inflammatory diseases
    Shi, Tingting
    Wu, Shuning
    Chen, Rongshan
    Xie, Yaping
    Yin, Genquan
    He, Chunhui
    Liang, Cuiping
    Lu, Gen
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [22] DUPILUMAB IMPROVES ASTHMA CONTROL IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA, REGARDLESS OF EXACERBATION HISTORY
    Corren, J.
    Castro, M.
    Maspero, J.
    Cosio, B.
    Kuna, P.
    Chen, Z.
    Staudinger, H.
    Chao, J.
    Nikhil, A.
    Ruddy, M.
    Akinlade, B.
    Graham, N.
    Teper, A.
    Khan, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S42 - S43
  • [23] Dupilumab efficacy in adolescents with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUEST
    Maspero, Jorge F.
    FitzGerald, John Mark
    Pavord, Ian D.
    Rice, Megan S.
    Maroni, Jaman
    Rowe, Paul J.
    Pirozzi, Gianluca
    Amin, Nikhil
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    Hardin, Megan
    ALLERGY, 2021, 76 (08) : 2621 - 2624
  • [24] Dupilumab in moderate-to-severe asthma
    Mellis, Craig
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2022, 58 (01) : 209 - 209
  • [25] Prevalence of Allergy and Type 2 Inflammatory Comorbidities in Adolescents With Uncontrolled, Moderate-to-Severe Asthma
    Jain, Neal
    Eghrari-Sabet, Jacqueline
    Daizadeh, Nadia
    Ortiz, Benjamin
    Pandit-Abid, Nami
    Deniz, Yamo
    Rowe, Paul
    PEDIATRICS, 2021, 147 (03)
  • [26] Dupilumab Effect on Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma with an Allergic Phenotype
    Castro, M.
    Corren, J.
    Casale, T. B.
    Quirce, S.
    Rice, M. S.
    Deniz, Y.
    Rowe, P.
    Amin, N.
    Teper, A.
    PNEUMOLOGIE, 2020, 74 : S89 - S89
  • [27] Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Asthma by Immunoglobin E Levels at Baseline
    Carr, Warner
    Jackson, David J.
    Corren, Jonathan
    Bergmann, Karl-Christian
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Amin, Nikhil
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [28] Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
    Castro, Mario
    Corren, Jonathan
    Casale, Thomas B.
    Quirce, Santiago
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Amin, Nikhil
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [29] Dupilumab Efficacy in LIBERTY ASTHMA QUEST Patients With Uncontrolled, Moderate-to-Severe Asthma By Allergen Sensitization Status
    Corren, Jonathan
    Jackson, David
    Casale, Thomas
    Borish, Larry
    Rabe, Klaus
    Busse, William
    Maspero, Jorge
    Jackson, Daniel
    Daizadeh, Nadia
    Ortiz, Benjamin
    Jacob-Nara, Juby
    Khodzhayev, Angela
    Rowe, Paul
    Djandji, Michel
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB15 - AB15
  • [30] Evaluating the Effect of Dupilumab on Type 2 Airway Inflammation and Mucus Plugging in Patients with Uncontrolled Moderate-To-Severe Asthma: the VESTIGE Trial
    Castro, Mario
    Papi, Alberto
    Porsbjerg, Celeste
    Lugogo, Njira
    Brightling, Christopher
    Gonzalez-Barcala, Francisco-Javier
    Bourdin, Arnaud
    Ostrovskyy, Mykola
    Staevska, Maria
    Chou, Pai-Chen
    Duca, Liliana
    Pereria, Ana
    Fogarty, Charles
    Nadama, Rufai
    Zhang, Mei
    Rodrigues, Amelie
    Soler, Xavier
    Pantelimon, Simona
    Sacks, Harry
    Deniz, Yamo
    Rowe, Paul
    Gomez, Lucia De Prado
    Jacob-Nara, Juby
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB368 - AB368